1. Home
  2. CNA vs GH Comparison

CNA vs GH Comparison

Compare CNA & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CNA Financial Corporation

CNA

CNA Financial Corporation

HOLD

Current Price

$46.67

Market Cap

12.0B

Sector

Finance

ML Signal

HOLD

Logo Guardant Health Inc.

GH

Guardant Health Inc.

HOLD

Current Price

$101.92

Market Cap

14.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNA
GH
Founded
1853
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.0B
14.1B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
CNA
GH
Price
$46.67
$101.92
Analyst Decision
Hold
Strong Buy
Analyst Count
1
21
Target Price
$53.00
$82.76
AVG Volume (30 Days)
468.6K
2.2M
Earning Date
11-03-2025
10-29-2025
Dividend Yield
8.25%
N/A
EPS Growth
N/A
N/A
EPS
3.66
N/A
Revenue
$14,850,000,000.00
$902,569,000.00
Revenue This Year
N/A
$34.72
Revenue Next Year
$21.34
$26.46
P/E Ratio
$12.73
N/A
Revenue Growth
5.41
30.38
52 Week Low
$43.29
$29.91
52 Week High
$51.34
$112.43

Technical Indicators

Market Signals
Indicator
CNA
GH
Relative Strength Index (RSI) 58.05 55.40
Support Level $43.80 $100.21
Resistance Level $47.04 $109.59
Average True Range (ATR) 0.70 4.22
MACD 0.01 -1.65
Stochastic Oscillator 82.54 13.51

Price Performance

Historical Comparison
CNA
GH

About CNA CNA Financial Corporation

CNA Financial Corporation (CNAF) is an insurance holding company that provides commercial property and casualty insurance. The company operates under five segments: Specialty, Commercial and International being its core business, and two segments for its non-core businesses, which are Life and Group and Corporate and Other. CNAF, through its segments, provides professional, financial, specialty property, and casualty products to small businesses and medium-scale organizations. It has its business spread across Continental Europe, United Kingdom, and Canada. The majority of the revenues are generated from the Specialty and Commercial segment of the business.

About GH Guardant Health Inc.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Share on Social Networks: